WILSON TROY EDWARD (President and CEO) purchased 35.8% of their position (100K shares) of KURA ONCOLOGY, INC. on the open market
Open‑market purchase worth $1.11M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/17/2026ACC: 0001193125-26-354201
DirectorOfficer· President and CEO
Since Nov 2018
+100K
Net shares
Net buyer
$1.11M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+100K
Price / share
$11.12
Trade value
$1.11M
% of position
35.8%
8/17/2026
279.19K→379.19K
Total
Net shares
+100K
Net value
$1.11M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/17/2026 | P · Purchase | +100K | $11.12 | $1.11M | 35.8% | 279.19K | 379.19K |
| Total | +100K | $1.11M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned300K
Common Stock
DirectShares owned435.46K
Total
435.46K direct·300K indirect735.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 300K | Indirect |
| Common Stock | 435.46K | Direct |
| Total | 735.46K | 435.46K direct·300K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported